Damora Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMRA and other ETFs, options, and stocks.About DMRA
Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2.
DMRA Key Statistics
Stock Snapshot
The current Damora Therapeutics(DMRA) stock price is $20.91, with a market capitalization of 1.29B. The stock trades at a price-to-earnings (P/E) ratio of -6.04.
During the trading session on 2026-06-09, Damora Therapeutics(DMRA) shares reached a daily high of $22.16 and a low of $20.36. At a current price of $20.91, the stock is +2.7% higher than the low and still -5.6% under the high.
Trading activity shows a volume of 302.09K, compared to an average daily volume of 391.74K.
The stock's 52-week range extends from a low of $2.45 to a high of $38.33.
The stock's 52-week range extends from a low of $2.45 to a high of $38.33.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.